Literature DB >> 9512373

Nitric oxide mediates behavioral signs of neuropathic pain in an experimental rat model.

Y W Yoon1, B Sung, J M Chung.   

Abstract

This study was conducted to determine whether nitric oxide (NO) is involved in the maintenance of behavioral signs of neuropathic pain induced by tightly ligating the left L5 and L6 spinal nerves. Neuropathic rats showed behavioral signs representing mechanical allodynia, cold allodynia and cold-stress exacerbated ongoing pain. Mechanical allodynia was suppressed by Nomega-nitro-L-arginine methyl ester (L-NAME; 200, 100, 50, 10 microM/kg, i.p.), a nitric oxide synthase inhibitor, in a dose-dependent manner. Cold allodynia and cold-stress exacerbated ongoing pain was also attenuated by L-NAME. Neither Nomega-nitro-D-arginine methyl ester (D-NAME; 200 microM/kg) nor saline changed any of the neuropathic pain behaviors. These results suggested that NO plays an important role in the maintenance of the behavioral signs of neuropathic pain and is involved in common steps in the maintenance of the different modalities of pain such as mechanical allodynia and cold allodynia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512373     DOI: 10.1097/00001756-199802160-00002

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

Review 1.  The role of nitric oxide in nociception.

Authors:  Z D Luo; D Cizkova
Journal:  Curr Rev Pain       Date:  2000

2.  PDZ domains at excitatory synapses: potential molecular targets for persistent pain treatment.

Authors:  Yuan-Xiang Tao; Roger A Johns
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

3.  Neuronal nitric oxide synthase mRNA upregulation in rat sensory neurons after spinal nerve ligation: lack of a role in allodynia development.

Authors:  Z D Luo; S R Chaplan; B P Scott; D Cizkova; N A Calcutt; T L Yaksh
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

4.  Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury.

Authors:  C A Fairbanks; K L Schreiber; K L Brewer; C G Yu; L S Stone; K F Kitto; H O Nguyen; B M Grocholski; D W Shoeman; L J Kehl; S Regunathan; D J Reis; R P Yezierski; G L Wilcox
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

5.  A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury.

Authors:  Wei-Ping Wu; Jing-Xia Hao; Ennio Ongini; Francesco Impagnatiello; Cristina Presotto; Zsuzsanna Wiesenfeld-Hallin; Xiao-Jun Xu
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

6.  Active leflunomide metabolite inhibits interleukin 1beta, tumour necrosis factor alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures.

Authors:  O Elkayam; I Yaron; I Shirazi; R Judovitch; D Caspi; M Yaron
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

7.  The analgesic effect of apelin-13 and its mechanism of action within the nitric oxide and serotonin pathways.

Authors:  M G Turtay; M Karabas; H Parlakpinar; C Colak; M Sagir
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

8.  Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents.

Authors:  S K Florio; C Loh; S M Huang; A E Iwamaye; K F Kitto; K W Fowler; J A Treiberg; J S Hayflick; J M Walker; C A Fairbanks; Y Lai
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

9.  Superoxide signaling in pain is independent of nitric oxide signaling.

Authors:  Hee Young Kim; Jigong Wang; Ying Lu; Jin Mo Chung; Kyungsoon Chung
Journal:  Neuroreport       Date:  2009-10-28       Impact factor: 1.837

10.  The selective neuronal nitric oxide synthase inhibitor 7-nitroindazole has acute analgesic but not cumulative effects in a rat model of peripheral neuropathy.

Authors:  Liliane J Dableh; James L Henry
Journal:  J Pain Res       Date:  2011-03-31       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.